12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·02/05/2026 17:05:45
Listen to the news
Gainers
- Estrella Immunopharma (NASDAQ:ESLA) shares moved upwards by 34.4% to $1.4 during Thursday's regular session. The market value of their outstanding shares is at $39.2 million.
- Liminatus Pharma (NASDAQ:LIMN) shares increased by 21.67% to $1.74. The company's market cap stands at $38.7 million.
- TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 20.39% to $10.33. The market value of their outstanding shares is at $7.8 million.
- Phibro Animal Health (NASDAQ:PAHC) stock rose 19.46% to $48.98. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q2 earnings report came out yesterday.
- AIM ImmunoTech (AMEX:AIM) stock increased by 19.43% to $1.26. The company's market cap stands at $3.4 million.
- CytoMed Therapeutics (NASDAQ:GDTC) stock increased by 18.83% to $1.01. The market value of their outstanding shares is at $9.9 million.
Losers
- CollPlant Biotechnologies (NASDAQ:CLGN) stock decreased by 41.0% to $0.95 during Thursday's regular session. The company's market cap stands at $20.5 million.
- Akanda (NASDAQ:AKAN) stock decreased by 22.23% to $0.91. The market value of their outstanding shares is at $2.4 million.
- Accuray (NASDAQ:ARAY) shares fell 21.43% to $0.59. The company's market cap stands at $85.7 million. The company's, Q2 earnings came out yesterday.
- Ernexa Therapeutics (NASDAQ:ERNA) stock fell 20.81% to $0.67. The company's market cap stands at $6.6 million.
- Ensysce Biosciences (NASDAQ:ENSC) stock decreased by 20.46% to $0.45. The market value of their outstanding shares is at $2.0 million.
- Aspire Biopharma Hldgs (NASDAQ:ASBP) stock decreased by 16.13% to $1.3. The company's market cap stands at $6.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.